Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMG-510 for Lung neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where AMG-510 was used for Lung neoplasm malignant.

Most Reported Side Effects for AMG-510

Side Effect Reports % Deaths Hosp.
Non-small cell lung cancer 134 36.7% 56 22
Hepatic cytolysis 48 13.2% 1 9
Death 33 9.0% 33 3
Diarrhoea 31 8.5% 3 10
Cholestasis 17 4.7% 0 6
Dyspnoea 9 2.5% 4 8
Alanine aminotransferase increased 8 2.2% 2 4
Colitis 7 1.9% 0 7
Dehydration 7 1.9% 0 7
Drug-induced liver injury 7 1.9% 0 5
Respiratory failure 7 1.9% 7 5
General physical health deterioration 6 1.6% 4 0
Hypokalaemia 6 1.6% 1 5
Pulmonary embolism 6 1.6% 1 5
Fatigue 5 1.4% 0 1

Other Indications for AMG-510

K-ras gene mutation (173) Non-small cell lung cancer (160) Non-small cell lung cancer metastatic (103) Non-small cell lung cancer stage iv (62) Lung adenocarcinoma (12)

Other Drugs Used for Lung neoplasm malignant

ERLOTINIB (9,207) OSIMERTINIB (4,754) NIVOLUMAB (4,197) PEMBROLIZUMAB (3,575) CARBOPLATIN (3,487) ALECTINIB (2,932) PEMETREXED (2,422) CRIZOTINIB (1,949) BEVACIZUMAB (1,810) PACLITAXEL (1,747)

Related Pages

AMG-510 Full Profile All Lung neoplasm malignant Drugs AMG-510 Demographics AMG-510 Timeline